Boulle Groups Tendyne is a company developing technologies for transcatheter mitral valve replacement, announced earlier in 2014 that it hadsecured $25 million in an oversubscribed Series C financing led by Apple Tree Partners, along with Boulle Group members and other existing investors. Proceeds will be used for validation of Tendynes novel Transcatheter Mitral Valve Implant to treat mitral regurgitation, including forthcoming clinical trials. ..privateequity/tag/boulle-group/prnewswire/news-releases/tendyne-raises-25-million-in-series-c-254620061.htmlinvesting.businessweek/research/stocks/private/snapshot.asp?privcapId=133834445crunchbase/organization/tendyne-holdingsthestreet/story/12972237/2/tendyne-announces-successful-first-human-implants-of-the-tendyne-transcatheter-mitral-valve-implant-tmvi.htmlcnbc/id/102233185
Posted on: Wed, 03 Dec 2014 21:42:54 +0000
Trending Topics
Recently Viewed Topics
© 2015